Trials / Unknown
UnknownNCT03063697
Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
Prospective, Multi-center, Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to Evaluate the Safety of DILATREND SR Cap. in Korean Patients with Essential hypertension, Chronic stable angina and Congestive heart failure for 52 weeks.
Conditions
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2017-02-24
- Last updated
- 2017-02-24
Source: ClinicalTrials.gov record NCT03063697. Inclusion in this directory is not an endorsement.